ATP5PDP1

Across TCGA pan-cancer cohorts, ATP5PDP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ATP5PDP1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ATP5PDP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5PDP1 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

COAD, STAD, and UCEC are the cancer types where ATP5PDP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5PDP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.241	.016	4	view →
STAD	Male	II,III,IV	−0.165	.010	3	view →
UCEC	All	IV	+0.290	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ATP5PDP1–COAD

Open the COAD breakdown →